Skip to main content

Home/ Dr. Goodyear/ Group items tagged los

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
star yu

El Nivel de Creatinina Subre desde 3.1 hasta 3.8 en Corto Tiempo Cuál es Su C... - 0 views

www.enfermedad-renal.com/...2807.html

creatinina Micro-Medicina China osmoterapia el tratamiento GFR

shared by star yu on 09 Jan 16 - No Cached
  • star yu on 09 Jan 16
     
    ¿El nivel de creatinina aumenta desde 3.1 hasta 3.8 en corto tiempo cuál es su causa ? De hecho, tanto de la dieta y el riñón dañado afectará el nivel de creatinina, pero los riñones dañados deben tomar la mayor parte de la culpa.
star yu

Si Mi Nivel de Creatinina Baja desde 8.6 hasta 5.4 Despúes de la Diálisis ,¿S... - 0 views

www.enfermedad-renal.com/...2805.html

el tratamiento la diálisis creatinina GFR

shared by star yu on 09 Jan 16 - No Cached
  • star yu on 09 Jan 16
     
    Mi nivel de creatinina baja desde 8.6 a 5.4 después de la diálisis, significa eso mi enfermedad va bien? Diálisis como uno de los tratamiento común de insuficiencia renal, puede disminuir el alto nivel de creatinina mediante la descarga de las toxinas adicionales de la sangre.
star yu

Medicina China es Mejor Regalo de Navidad para el Paciente de Síndrome Nefrótico - 0 views

www.hospitalrenal.com/...1097.html

la función renalSíndrome nefróticoel tratamientola medicina china tradicional

shared by star yu on 20 Dec 15 - No Cached
  • star yu on 20 Dec 15
     
    Medicina China es mejor regalo de Navidad para el paciente de sindrome nefrótico .A menudo , nos quieren dar las cosas buenas que nuestro hijos y ayudarles a lograr un futuro brillante ,pero el sindrome nefrótico puede destruir este sueño , porque nuestros hijos tienen que ser atormentado con la recidiva frecuente de síndrome nefrótico constantemente. Se acerca la Navidad pronto. ¿Sigue dudando de elegir los regalos para su hijo? Creo que el mejor regalo que puede ser la salud. La medicina china puede ser una buena opción para usted.
star yu

El Paciente de Uremia Ha Visto la Esperanza de Librarse de la Diálisis - 0 views

www.enfermedad-renal.com/...2746.html

el tratamiento la medicina china tradicional medicinal Terapia Baño diálisis uremia

shared by star yu on 20 Dec 15 - No Cached
  • star yu on 20 Dec 15
     
    13 del Octubre de 2015, KABU ERNEST AKUAKU llegó a nuestro hospital para recibir tratamiento adicional, los siguientes son algunos detalles sobre él y trato que recibió aquí.
star yu

La Medicina China es Mejor que la Diálisis para los Pacientes de Insuficienci... - 0 views

www.hospitalrenal.com/...1096.html

el tratamientola medicina china tradicionalla diálisisGFR

shared by star yu on 20 Dec 15 - No Cached
  • star yu on 20 Dec 15
     
    Soy un paciente de insuficiencia renal ,y recientemente mi GFR baja en 8 rápidamente ,mi nivel de creatinina aumenta a 13.Por cierto,yo todavía tengo buena producción de orina. Soy un paciente de insuficiencia renal ,y recientemente mi GFR baja en 8 rápidamente ,mi nivel de creatinina aumenta a 13.Por cierto,yo todavía tengo buena producción de orina.
star yu

El Trasplante Renal es la Mejor Operación para los Pacientes de Insuficiencia... - 0 views

www.enfermedad-renal.com/...2754.html

la insuficiencia renal creatinina el tratamiento trasplante

shared by star yu on 21 Dec 15 - No Cached
  • star yu on 21 Dec 15
     
    Mi hermana es un paciente de insuficiencia renal ,recientemente sufre muchos síntomas como acidiosos metabólica ,anemia, hiperfosfatemia, hipocalcemia, osteodistrofia renal, la deficiencia de vitamina D, la hipertensión secundaria, estreñimiento, etc. El doctor le recomienda que ella tome el trasplante renal, que quiero saber es que es una opción inteligente para ella?
star yu

La Medicina China Trace una Nueva Esperanza al Paciente de la Diálisis - 0 views

www.hospitalrenal.com/...1103.html

Micro-Medicina China osmoterapiala insuficiencia renalel tratamientoMaikang ComposiciónPie Terapia BañeraBaño Medicinal

shared by star yu on 21 Dec 15 - No Cached
  • star yu on 21 Dec 15
     
    Auwalu Nura Sani es un paciente de insuficiencia renal que ya ha tomado la dislalia 3 años,este es la segunda vez de venir a nuestro hospital para reducir el tratamiento .Los siguientes son las detalles sobre él ,vamos a echar un vistazo juntos.
star yu

Los Tratamientos Nuevos en Shijiazhuang Hospital de Enfermedades de Riñon - 0 views

www.enfermedad-renal.com/...3003.html

Micro-Medicina Chian osmoterapia Medicina China oral Baño Medicinal el tratamiento Shijiazhuang Hospital de Enfermedades del Riñón

shared by star yu on 28 Mar 16 - No Cached
  • star yu on 28 Mar 16
     
    Shijiazhuang Hospital de Enfermedades del Riñón como el hospital más grande para curar la enfermedad renal especialmente en china, ha creado muchos tratamiento s únicos y eficaces sobre enfermedades renales, ayudando a más y más pacientes con enfermedad renal viven una vida de alta calidad.
star yu

¿En Qué Tratamiento Puede Tratar para la Creatinina 4.2? - 0 views

www.hospitalrenal.com/...1366.html

la función renalMicro-Medicina China osmoterapiala creatininael tratamiento

shared by star yu on 05 Apr 16 - No Cached
  • star yu on 05 Apr 16
     
    Para los pacientes, tal vez no saben qué es el nivel de creatinina ni la causa de eso, ni siquiera un tratamiento para bajarla. En este artículo, vamos a responderlos. ¿Cuál es el nivel de creatinina? La creatinina es un producto del metabolismo muscular en el cuerpo humano, se excreta por filtración glomerular principalmente.
Nathan Goodyear

Intravenous Ascorbate as a Tumor Cytotoxic Chemotherapeutic Agent - 0 views

www.seanet.com/...d_hypotheses_1995-v44-p207.htm

vitamin C cancer IV vitamin C ascorbic acid

shared by Nathan Goodyear on 05 Mar 18 - No Cached
  • There is a 10 — 100-fold greater content of catalase in normal cells than in tumor cells
  • induce hydrogen peroxide generation
  • Ascorbic acid and its salts (AA) are preferentially toxic to tumor cells in vitro (6 — 13) and in vivo
  • ...36 more annotations...
  • related to intracellular hydrogen peroxide generation
  • only be obtained by intravenous administration of AA
  • Preferentially kills neoplastic cells
  • Is virtually non-toxic at any dosage
  • Does not suppress the immune system, unlike most chemotherapy agents
  • Increases animal and human resistance to infectious agents by enhancing lymphocyte blastogenesis, enhancing cellular immunity, strengthening the extracellular matrix, and enhancing bactericidal activity of neutrophils and modulation of complement protein
  • Strengthens the structural integrity of the extracellular matrix which is responsible for stromal resistance to malignant invasiveness
  • 1969, researchers at the NCI reported AA was highly toxic to Ehrlich ascites cells in vitro
  • In 1977, Bram et al reported preferential AA toxicity for several malignant melanoma cell lines, including four human-derived lines
  • Noto et al reported that AA plus vitamin K3 had growth inhibiting action against three human tumor cell lines at non-toxic levels
  • Metabolites of AA have also shown antitumor activity in vitro
  • The AA begins to reduce cell proliferation in the tumor cell line at the lowest concentration, 1.76 mg/dl, and is completely cytotoxic to the cells at 7.04 mg/dl
  • the normal cells grew at an enhanced rate at the low dosages (1.76 and 3.52 mg/dl)
  • preferential toxicity of AA for tumor cells. >95% toxicity to human endometrial adenocarcinoma and pancreatic tumor cells (ATCC AN3-CA and MIA PaCa-2) occurred at 20 and 30 mg/dl, respectively.
  • No toxicity or inhibition was demonstrated in the normal, human skin fibroblasts (ATCC CCD 25SK) even at the highest concentration of 50 mg/dl.
  • the use of very high-dose intravenous AA for the treatment of cancer was proposed as early as 1971
  • Cameron and Pauling have published extensive suggestive evidence for prolonged life in terminal cancer patients orally supplemented (with and without initial intravenous AA therapy) with 10 g/day of AA
  • AA, plasma levels during infusion were not monitored,
  • the long-term, oral dosage used in those experiments (10 g/day), while substantial and capable of producing immunostimulatory and extracellular matrix modulation effects, was not high enough to achieve plasma concentrations that are generally cytotoxic to tumor cells in culture
  • This low cytotoxic level of AA is exceedingly rare
  • 5 — 40 mg/dl of AA is required in vitro to kill 100% of tumor cells within 3 days. The 100% kill levels of 30 mg/dl for the endometrial carcinoma cells and 40 mg/dl for the pancreatic carcinoma cells in Figure 2 are typical
  • normal range (95% range) of 0.39-1.13 mg/dl
  • 1 h after beginning his first 8-h infusion of 115 g AA (Merit Pharmaceuticals, Los Angeles, CA), the plasma AA was 3.7 mg/dl and at 5 h was 19 mg/dl. During his fourth 8-h infusion, 8 days later, the 1 h plasma level was 158 mg/dl and 5 h was 185 mg/dl
  • plasma levels of over 100 mg/dl have been maintained in 3 patients for more than 5 h using continuous intravenous infusion
  • In rare instances of patients with widely disseminated and rapidly proliferating tumors, intravenous AA administration (10 — 45 g/day) precipitated widespread tumor hemorrhage and necrosis, resulting in death
  • Although the outcomes were disastrous in these cases, they are similar to the description of tumor-necrosis-factor-induced hemorrhage and necrosis in mice (52) and seem to demonstrate the ability of AA to kill tumor cells in vivo.
  • toxic effects of AA on one normal cell line were observed at 58.36 mg/dl and the lack of side effects in patients maintaining >100 mg/dl plasma levels
  • Although it is very rare, tumor necrosis, hemorrhage, and subsequent death should be the highest priority concern for the safety of intravenous AA for cancer patients.
  • Klenner, who reported no ill effects of dosages as high as 150 g intravenously over a 24-h period
  • Cathcart (55) who describes no ill effects with doses of up to 200 g/d in patients with various pathological conditions
  • following circumstances: renal insufficiency, chronic hemodialysis patients, unusual forms of iron overload, and oxalate stone formers
  • Screening for red cell glucose-6-phosphate dehydrogenase deficiency, which can give rise to hemolysis of red blood cells under oxidative stress (57), should also be performed
  • any cancer therapy should be started at a low dosage to ensure that tumor hemorrhage does not occur.
  • patient is orally supplementing between infusions
  • a scorbutic rebound effect can be avoided with oral supplementation. Because of the possibility of a rebound effect, measurement of plasma levels during the periods between infusions should be performed to ensure that no such effect takes place
  • Every effort should be made to monitor plasma AA levels when a patient discontinues intravenous AA therapy.
  • Nathan Goodyear on 05 Mar 18
     
    Older study, 1995, but shows the long-standing evidence that IVC preferentially is cytotoxic to cancer cells.`
vanh14297

Testosteron Booster - Khẳng định đẳng cấp phái mạnh - 1 views

Mạnh mẽ, tự tin, lâu dài,... đó là những gì mà người đàn ông nào cũng mong muốn mình sẽ thể hiện được với người phụ nữ của mình. Đừng lo nếu như bạn chưa có đủ những yếu tố trên vì từ bây giờ, Test...

Testosterone hormone hormones Male men disease low

started by vanh14297 on 23 May 22 no follow-up yet
« First ‹ Previous 361 - 371 of 371
Showing 20▼ items per page